NEW YORK — Diazyme Laboratories said on Thursday that it signed an agreement to market and distribute Maccura Biotechnology's SARS-CoV-2 molecular diagnostic in the US.
Specific terms of the deal were not disclosed.
NEW YORK — Diazyme Laboratories said on Thursday that it signed an agreement to market and distribute Maccura Biotechnology's SARS-CoV-2 molecular diagnostic in the US.
Specific terms of the deal were not disclosed.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.
Privacy Policy. Terms & Conditions. . Copyright © 2021 GenomeWeb, a business unit of Crain Communications. All Rights Reserved.